Gene Therapy Development for Glaucoma

Postado 2024-04-11 07:56:51

884

Glaucoma is a complex disease, and currently the only way to maintain patient health is by lowering intraocular pressure. Gene therapy to treat the disease is rapidly evolving. This is a much needed area of glaucoma treatment that can be applied to a variety of glaucoma types.

A major risk factor for glaucoma is high IOP and causes blindness primarily due to RGC damage and death. Therefore, Ace Ophthalmology provides gene therapy development services for glaucoma, targeting candidate genes related to IOP and RGC, as well as many other related genes and pathways.

Learn more：glaucoma gene delivery system development service

Faça Login para curtir, compartilhar e comentar!

Outro

Recruitment Process Outsourcing Market : Size, Growth, Trends, and Forecast Analysis: Opportunities and Challenges

The Recruitment Process Outsourcing (RPO) Market Size was valued at USD 8.52 Billion in 2023 and...

Por 2024-07-24 07:07:56 0 501

Outro

CCSK Exam Questions - Real CCSK PDF Dumps For Prep

Importance of CCSK Exam Dumps [2022] | With Updated CCSK Questions CertsMentor is the...

Por 2022-09-26 08:06:42 0 2K

Outro

Bifurcation Lesions Market Size Worth USD 888.2 Million By 2032

Market Summary: The global market for bifurcation lesions reached a size of USD 624 million in...

Por 2023-11-03 07:24:10 0 1K

Art

K-TECH's Mission: Technology for Sustainable Growth

K-TECH is a Vietnamese technology company devoted to offering a selection of digital services to...

Por 2024-10-28 10:40:26 0 230

Outro

Lithium-ion Battery Recycling Market 2030: Regional Insights and Growth Projections

Lithium-ion Battery Recycling Market Growth & Trends The global lithium-ion battery...

Por 2024-12-13 11:00:45 0 28